View all jobs
Financial and Strategy Consultant for pharma global services - July 2023
remote, remoteFor one of our clients we are looking for a Financial and Strategy consultant for Global Services
Project name:
Opportunity Assessment for Global Services in the area of „Evidence Creation, Value Management and Market Access”
Description:
Tasks:
Required skills:
Possible timelines to be kept:
A preliminary version of the report needs to be available no later than early/ mid of September. Final version can take a little longer. A study duration of around 6-8 weeks is expected.
Start: ASAP
Duration: 2 months+
Location: mainly remote, onsite in Ingelheim only if needed
Project name:
Opportunity Assessment for Global Services in the area of „Evidence Creation, Value Management and Market Access”
Description:
- Human Pharma Services (HPS) is an industrial scale, global shared services organization, that was established in BI in 2019. It mainly operates in the areas of Commercial and Medical Affairs Operations. A large scale offshore Digital Factory run by a global production partner is coding/ producing all emails, edetails, websites and banners for BI worldwide. A captive center in Barcelona is providing less standardized and more customer-centric services in adjacent fields around Digital Marketing and Medical Affairs using and managing (DAM) the assets produced in offshore India.
- The service is requested as part of the Long-Term Forecast Planning, that is constantly describing and quantifying opportunities for the further evolution and growth of HPS and the area of evidence creation, value management and market access was identified as one more global opportunity. So far, there are no services offered in these areas of expertise and there is no one available internally, who brings the right expertise that can connect the area of evidence creation, value management and market access with the concept of global, shared services. The combination of these two areas is critical for the success of this project.
- The objective of the project is to draft a high-level business case, that is mapping out the global services opportunity for BI/ HPS. This business case needs to come up with a quantified set of prioritized activities (i.e., service catalog and savings) that could be developed and delivered in a Wave 1 from 2024 onwards.
Tasks:
- Consultation of relevant areas for an analysis of the external spend, based on the contractor’s expertise
- Analysis of the external spend in the relevant areas (to be defined by BI, based on consultation by the Contractor) of investigation (data to be provided by global sourcing)
- Identifying the key activities, services and deliverables provided by external agencies that could be internalized and centralized, by interviewing defined group of internal stakeholders and reviewing pre-identified scope of
- Conducting a series of interviews with pre-defined key stakeholders from the Corp TAs, the Functions (mainly HEOR and RWE) and selected colleagues from the regional centers and key markets to understand the overall evidence strategy and key challenges, opportunities and pain points (SWOT analysis)
- Create a long list of potential activities and services that can be harmonized and centralized
- Create a short list by consolidating and ranking of the long list according to their overall potential for centralization, savings and support opportunity
- The performance of the contractor has the goal to provide a detailed report and business case including clear recommendations for where and how to start the centralization journey including rational for the recommendation.
Required skills:
- 5-10 years of experience in similar projects and Global Services
- Pharma Experience required
- Former Expertise in Strategy Consulting (possibly worked for a big consulting agency)
- English mandatory
- CET-close Timezone
- Master (or higher Qualification) in Economics
- Expertise in evidence creation, value management and market access and global shared services
Possible timelines to be kept:
A preliminary version of the report needs to be available no later than early/ mid of September. Final version can take a little longer. A study duration of around 6-8 weeks is expected.
Start: ASAP
Duration: 2 months+
Location: mainly remote, onsite in Ingelheim only if needed